Cite Filings / TWST / 0001193125-26-349307
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G/A

Statement of Beneficial Ownership

Twist Bioscience Corp · Filed 2026-08-13 · Acc 0001193125-26-349307

Documents 1

  • SCHEDULE 13G/A Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-08-14 4 Chief Executive Officer sold 19,952 shares at $125.08 ($2,495,508)
  • 2026-08-14 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-13 SCHEDULE 13G/A Statement of Beneficial Ownership
  • 2026-08-12 144 Sale of Securities
  • 2026-08-12 144 Sale of Securities
  • 2026-08-12 4 Chief Executive Officer sold 113,318 shares at $125.16 ($14,183,051)
  • 2026-08-11 SCHEDULE 13G/A Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G/A · T. Rowe Price Associates, Inc. 9.2%
  2. 2026-08-14 SCHEDULE 13G/A · EdgePoint Investment Group Inc. 4.21%
  3. 2026-02-17 SCHEDULE 13G/A · EdgePoint Investment Group Inc. 8.80%
  4. 2025-11-14 SCHEDULE 13G · EdgePoint Investment Group Inc. 6.76%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…